Akoya Biosciences (NASDAQ:AKYA) Price Target Cut to $6.00 by Analysts at Canaccord Genuity Group

Akoya Biosciences (NASDAQ:AKYA – Free Report) had its price objective cut by Canaccord Genuity Group from $10.00 to $6.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages have also recently weighed in on AKYA. BTIG Research dropped their price target […]

Related Keywords

United States ,America ,Asia Pacific ,Brian Mckelligon ,Akoya Biosciences ,Canaccord Genuity Group ,Akoya Biosciences Inc ,Schonfeld Strategic Advisors ,Akoya Biosciences Company Profile ,Asset Management Inc ,Tower Research Capital ,York Mellon Corp ,Nisa Investment Advisors ,Jpmorgan Chase Co ,Free Report ,Moderate Buy ,Get Free Report ,Investment Advisors ,Research Capital ,Management Inc ,Strategic Advisors ,New York Mellon Corp ,North America ,Middle East ,Akoya Biosciences Daily ,